BETHANNE CARSON: Open Payments
NPI 1780931154 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,005 in 159 payments from 18 companies in 2025. Trend: 2023 $2,833 · 2024 $2,831 · 2025 $3,005
Food & beverage: $2,901Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $463 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $358 |
| Otsuka America Pharmaceutical, Inc. | 16 | $317 |
| Teva Pharmaceuticals USA, Inc. | 12 | $266 |
| Janssen Pharmaceuticals, Inc | 6 | $208 |
| Alkermes, Inc. | 14 | $204 |
| Corium, LLC | 11 | $192 |
| Axsome Therapeutics, Inc. | 16 | $174 |
| Neurocrine BioSciences, Inc. | 10 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $136 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, Azstarys, ZURZUVAE, Auvelity, INGREZZA.
Industry payments across LA — which companies pay providers there.
